Immutep (ASX:IMM) - Webinar Presentation

23/06/2023 17:09:00

This video is not supported on your device. Click here for the original version.
Marc Voigt - Executive Director & CEO - Immutep (ASX:IMM) is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 immunotherapy for cancer and autoimmune diseases.